Related Experiment Video
Updated: Jun 2, 2026

Investigating the Alleviating Effects of Bacillus cereus Administration on Colitis through Gut Microbiota Modulation
Published on: July 27, 2022
[Biochemical criteria for severity of colonic dysbacteriosis]
Abstract:
The purpose of the investigation was to estimate the content of malondialdehyde (MDA) in the coprofiltrates of human beings with bacteriologically verified colonic dysbacteriosis and to clarify a relationship of the amount of MDA in the coprofiltrates to the degree of the abnormal qualitative and quantitative composition of microbiocenosis. Specimens from 109 subjects aged 19 to 56 years were examined. The change in the level of MDA in the coprofiltrates was found to correspond to the impairment in the composition of microbiocenosis. The comparison of the coprofiltrate content of MDA with enteric microbiocenotic changes allows one to consider that MDA levels may serve as a biochemical criterion for the degree of dysbacteriosis and be used as an additional method for its diagnosis.
Related Concept Videos
Dysbiosis of the Gut Microbiota
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease II: Ulcerative Colitis
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease I: Introduction
Inflammatory Bowel Disease IV: Clinical Manifestations

